The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291.
Union Pacific Corporation
UNP · a US exchange · USD · Market cap $176.4B · 28,647 employees
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates in the railroad business in the United States.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price302.44 USD at the 13 Nov 2026 close
- Our value readFair vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.68)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $220.50 to $347.48, base estimate $302.16 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political selling, disclosed 2026-10-07
- Options put/call open interest 0.68, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Union Pacific Corporation holds its Markup at $302.44. Consolidating, no directional conviction, held for 350 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 350 days |
| Price at the screen | $302.44 |
| Valuation | 23.17 trailing · 20.63 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.85 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 47.09% | Below 33% | Interest-bearing debt is 47.1% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 4.14% | Below 33% | Cash held in interest-bearing accounts and securities is 4.1% of assets, under the one-third limit. | Pass |
| Receivables | 4.49% | Below 49% | Money owed to the company is 4.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.23% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Union Pacific's business is in a permissible area, but its interest-bearing debt is about 47% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when UNP's ethical verdict changes
Today UNP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades above our $302.16 fair value estimate, strong competitive moat, 15.30% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 0.1% above the base estimate.
Third-party analyst targets: 24 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $302.16, with a range of $220.50 to $347.48, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it is worth knowing
A quality business: a strong moat and 29% profit margins. At the screened price it sits 0% above our $302.16 fair value: priced for the quality, not a bargain.
| Forward P/E | 20.6xpriced for continued growth |
| Trailing P/E | 23.2xa premium valuation |
| EPS, trailing | 12.82 |
| EPS, forward | 14.39 |
| Revenue growth | +15.3%steady growth |
| Profit margin | 28.9%healthy profit margins |
| Return on equity | 38.7%an exceptional return on shareholder capital |
| FCF yield | 2.87% |
| Dividend yield | 2.08% |
| Debt to equity | 1.41a meaningful debt load worth watching |
| Current ratio | 1.16adequate liquidity, worth monitoring |
| Beta | 0.85steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 219.89 - 315.99 |
| Moat | STRONG |
| Market cap | $176.4B |
| Employees | 28,647 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeUNP trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (22 analysts) rates it buy, with a mean price target of $291. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Could You Have Seen The Run In CSX Stock Coming? Yahoo Finance · 3d ago
- Amid Stubborn Diesel Prices, These Railroad Stocks Eye Breakouts Yahoo Finance · 3d ago
- 3 Legacy Industrial Dividend Stocks That Never Go Out of Style Yahoo Finance · 4d ago
- Can Wabtec's Raised 2026 Earnings Outlook Support Its Next Leg Higher? Yahoo Finance · 4d ago
- Divided Government Is Back: 4 Steady Passive Income Dividend Stocks to Own Yahoo Finance · 4d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | ROCKER KENYATTA G. | Officer | 16 | $4,244 | |
| 2026-05-08 | POWERS CARRIE J. | Officer | 5 | $1,580 | |
| 2026-05-08 | HAMANN JENNIFER L | Chief Financial Officer | 8 | $2,325 | |
| 2026-05-08 | JALALI RAHUL | Chief Technology Officer | 9 | $2,400 | |
| 2026-05-08 | CONLIN CHRISTINA B | Officer | 7 | $1,905 | |
| 2026-05-08 | GEHRINGER ERIC J. | Officer | 14 | $3,750 | |
| 2026-04-24 | ROCKER KENYATTA G. | Officer | 27,387 | $4,806,048 | |
| 2026-04-24 | ROCKER KENYATTA G. | Officer | 27,387 | $7,442,691 | |
| 2026-04-24 | HAMANN JENNIFER L | Chief Financial Officer | 2,000 | $549,400 | |
| 2026-04-10 | VENA VINCENZO JIM | Chief Executive Officer | 11 | $3,000 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-07 | Ro Khanna | Democrat | sell | 15K–50K |
| 2026-05-15 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-05-01 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-03-27 | Alan Armstrong | Republican | buy | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $261.99 | +1.9% | $1.38 | $1,025 | +2.5% |
| 2 months | $249.22 | +7.2% | $1.38 | $1,077 | +7.7% |
| 3 months | $242.84 | +10.0% | $1.38 | $1,105 | +10.5% |
| 6 months | $233.68 | +14.3% | $2.76 | $1,155 | +15.5% |
| 1 year | $221.57 | +20.5% | $5.52 | $1,230 | +23.0% |
| 2 years | $218.87 | +22.0% | $10.88 | $1,270 | +27.0% |
| 3 years | $186.67 | +43.1% | $16.08 | $1,517 | +51.7% |
| 5 years | $197.70 | +35.1% | $26.01 | $1,482 | +48.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever UNP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.